Clearsense Named in 2025 Gartner Case Study on Legacy Decommissioning

Uncover the strategies Trinity Health used to achieve significant cost savings through legacy application decommissioning

NASHVILLE, Tenn., Aug. 25, 2025 /PRNewswire/ — Clearsense®, a cloud-based data enablement platform company, is excited to announce its inclusion in a new Gartner® report called: “Case Study: Trinity Health Drives IT Cost Optimization with Legacy Decommissioning” by Barry Runyon (June 27, 2025).

“We’ve built a deeply collaborative partnership with Trinity Health and are proud to support what some analysts consider to be the largest and most impactful active archiving initiatives in U.S. healthcare,” said Clearsense CEO Jason Z. Rose. “With health systems dealing with immense economic headwinds largely due to more than a trillion dollars of Medicaid and ACA funding cuts, we believe this gives health system leaders a blueprint for rapidly reducing bloated IT costs.”

According to Mike Prokic, Chief IT Strategy Officer at Trinity Health:

“Our earlier attempt at decommissioning retired just six applications over two years. Working with Clearsense, we established a repeatable, governance-led process that now retires 20 to 25 systems each quarter. This long-term strategic effort supports cost optimization, M&A integration, risk reduction, and innovation across the organization. It has positioned us to achieve substantial savings while enabling future use cases and other areas of innovation.”

Click here to download a complimentary copy of the Gartner case study and learn more about how Trinity Health drove cost optimization with legacy decommissioning by engaging Clearsense.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Clearsense
Clearsense is a healthcare data enablement platform that helps health systems save millions, reduce risk, and unlock innovation. Its 1Clearsense™ platform eliminates “zombie apps”—redundant legacy systems that drain resources—through active archiving that unifies data at unprecedented velocity and scale. The platform streamlines operations, strengthens compliance, and fuels advances in analytics, AI, and research—ultimately revitalizing healthcare data. Learn more at clearsense.com.

Media Contact:
Andrea LePain
andrea@emediajunction.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/clearsense-named-in-2025-gartner-case-study-on-legacy-decommissioning-302536266.html

SOURCE Clearsense

Staff

Recent Posts

GaraHerb Supplement Facts, Ingredient Label Details, and Product Disclosures: A 2026 Informational Overview of Male Enhancement Supplement Options

Label-verified GaraHerb ingredient disclosures, manufacturing and policy transparency details, and what consumers searching for GaraHerb…

13 hours ago

Cannabix Technologies announces Non-Brokered LIFE Private Placement

  NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…

13 hours ago

LuminEye Nano-Drops Product Information Updated as Consumer Interest in Eye Health Supplement Options and Vision Support Alternatives Grows in 2026

An informational overview examining category context, publicly available product disclosures, and what consumers often consider…

13 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”)…

13 hours ago

Laughland Teeth Whitening Kit: Ingredients, Disclosures, and What Consumers Are Researching in 2026

A 2026 informational overview of the Laughland whitening kit covering publicly available ingredient disclosures, product…

13 hours ago

The UA Sprinkler Fitters Local 669 JATC – Notice of Privacy Incident

Landover, Maryland, February 6, 2026- The UA Sprinkler Fitters Local 669 Joint Apprenticeship and Training…

22 hours ago